A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of ONO-2333Ms in patients with recurrent major depressive disorder.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 30 Nov 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

21 Oct 2011 Actual end date changed from Apr 2008 to Jun 2008 as reported by ClinicalTrials.gov.
12 Nov 2008 Updated end date and actual patient number as reported in ClinicalTrials.gov record.
12 Nov 2008 Status changed from active, no longer recruiting to completed, as reported in ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com